IBEX IBEX

IBEX Limited Announces Second Quarter Fiscal Year 2021 Financial Results

IBEX Limited Announces Second Quarter Fiscal Year 2021 Financial Results

Second Quarter Fiscal Year 2021

  • Record revenue of $117.2 million, representing an increase of 8.7% year-over-year
  • Net income was $2.5 million (non-GAAP adjusted net income of $6.2 million)
  • Adjusted EBITDA increased 18.7% to $17.6 million, achieved record adjusted EBITDA margin of 15.0%
  • Company raises fiscal year 2021 guidance

WASHINGTON, Feb. 18, 2021 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”), a leading global provider of outsourced CX solutions, today announced financial results for three and six months ended December 31, 2020.

“In May 2015, when I joined ibex as CEO, I set out on a vision to be a growth leader, a leader in the nearshore markets and to push to and above 15% adjusted EBITDA,” said Bob Dechant, Chief Executive Officer of ibex. “I am proud to report that we are achieving each of these goals and delivered a record second quarter. Revenues increased to an all-time high of $117.2 million, as our organic growth continues to outpace the industry. We received the very prestigious Frost and Sullivan Central America and Caribbean CX Company of the year award which validates and distinguishes our success in the nearshore market. And lastly, we reported 15% adjusted EBITDA for the quarter!”

Dechant continued, “We had full focus on execution this quarter – delivering on the critical seasonal ramps for our clients. As evidenced by our results, we had a stellar quarter of performance. Despite the growing cases of COVID-19 throughout the world, we continued managing all of our centers and kept all of our Work@Home employees operational. In addition, during the quarter we launched a new center in Jamaica, expanded in the Philippines, we won several key new logos, and we grew our sales pipeline to position us for growth in the second half of 2021 and beyond.”



Second Quarter Fiscal Year 2021 Financial Highlights:



Revenue

  • Revenue increased 8.7% to $117.2 million, compared to $107.8 million in the prior year quarter.

Net Income

  • Net income was $2.5 million, including $1.6 million in non-recurring costs, compared to net income of $4.8 million in the prior year quarter.
  • Non-GAAP adjusted net income increased to $6.2 million, compared to $5.6 million in the prior year quarter (see Exhibit 1 for reconciliation).
  • Net margin was 2.1%, compared to 4.4% in the prior year quarter.
  • On a Non-GAAP basis, net margin increased to 5.3%, compared to 5.2% in the prior year quarter (see Exhibit 1 for reconciliation).

Adjusted EBITDA

  • Non-GAAP adjusted EBITDA, increased to $17.6 million, compared to $14.8 million in the prior year quarter (see Exhibit 2 for reconciliation).
  • Non-GAAP adjusted EBITDA margin increased to 15.0%, compared to 13.8% in the prior year quarter.

Earnings Per Share

  • IFRS basic and fully diluted earnings per share was $0.14 and $0.13, respectively, compared to IFRS basic and fully diluted earnings per share of $0.00 and $0.00, respectively, in the prior year quarter.*
  • Non-GAAP pro forma fully diluted adjusted earnings per share (see Exhibit 1 for reconciliation) increased to $0.33, compared to $0.30 in the prior year quarter.

* IFRS fully diluted earnings per share for the three and six months ended December 31, 2019 does not reflect the recapitalization that occurred in connection with ibex’s August 7, 2020 initial public offering.



Balance Sheet

  • Strong cash position of $74.6 million compared to $21.9 million at June 30, 2020.
  • Non-GAAP net debt (see Exhibit 4 below) decreased to $50.7 million, compared to $84.1 million as of June 30, 2020.

Second Quarter of Fiscal Year 2021 Business Highlights:

  • Top three client concentration decreased to 36.4% from 45.1% in the prior year quarter
  • Won 3 new customer logos across key verticals, including healthcare and utilities
  • Opened a new 1,200 seat center in Jamaica and added 600 seats in the Philippines
  • New Economy revenue increased by 10.5% compared to the prior year quarter, and when adjusted for one client that was adversely impacted by the pandemic, New Economy revenue increased by 28.1%.

Raised Fiscal Year 2021 Business Outlook

We are raising our fiscal year 2021 guidance for revenue to between $445 million and $448 million, an increase of approximately 10% over the prior year, compared to $440 million to $443 million previously provided.

Adjusted EBITDA is now expected to be between $62.0 million and $63.5 million, an increase of approximately 14% to 17% over the prior year, compared to $60.5 million to $62.0 million previously provided.

Conference Call and Webcast Information

IBEX Limited will host a conference call and live webcast to discuss its second quarter of fiscal year 2021 financial results at 4:30 p.m. Eastern Time today, February 18, 2021. To access the conference call, dial (833) 614-1408 for the U.S. or Canada, or for international callers (914) 987-7129 and provide conference ID 6963453. The webcast will be available live on the Investors section of ibex's website at: .

An audio replay of the call will also be available to investors beginning at approximately 7:30 p.m. Eastern Time on February 18, 2021, until 7:30 p.m. Eastern Time on February 25, 2021, by dialing (855) 859-2056 for the U.S. or Canada, or for international callers, (404) 537-3406 and entering passcode 6963453. In addition, an archived webcast will be available on the Investors section of ibex's website at: .

Financial Information

While the financial figures included in this press release have been computed in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) applicable to interim periods, this announcement does not contain sufficient information to constitute an interim financial report as defined in International Accounting Standards 34, “Interim Financial Reporting.” The financial information in this press release has not been audited.

ibex is not providing a quantitative reconciliation of forward-looking non-GAAP adjusted EBITDA to the most directly comparable IFRS measure because it is unable to predict with reasonable certainty the ultimate outcome of certain significant items without unreasonable effort. These items include, but are not limited to, non-recurring expenses, fair value adjustments, share-based compensation expense, and impairment of assets. These items are uncertain, depend on various factors, and could have a material impact on IFRS reported results for the guidance period.

Non-GAAP Financial Measures

We present non-GAAP financial measures because we believe that they and other similar measures are widely used by certain investors, securities analysts and other interested parties as supplemental measures of performance and liquidity. We also use these measures internally to establish forecasts, budgets and operational goals to manage and monitor our business, as well as evaluate our underlying historical performance, as we believe that these non-GAAP financial measures depict the true performance of the business by encompassing only relevant and controllable events, enabling us to evaluate and plan more effectively for the future. The non-GAAP financial measures may not be comparable to other similarly titled measures of other companies and have limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of our operating results as reported under IFRS as issued by the IASB. Non-GAAP financial measures and ratios are not measurements of our performance, financial condition or liquidity under IFRS as issued by the IASB and should not be considered as alternatives to operating profit or net income / (loss) or as alternatives to cash flow from operating, investing or financing activities for the period, or any other performance measures, derived in accordance with IFRS as issued by the IASB or any other generally accepted accounting principles.

About ibex

ibex helps the world’s preeminent brands more effectively engage their customers with services ranging from customer support, technical support, inbound/outbound sales, business intelligence and analytics, digital demand generation, and CX surveys and feedback analytics.

Forward Looking Statements

In addition to historical information, this release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. These statements include, but are not limited to, statements regarding our future financial and operating performance, including our outlook and guidance, and our strategies, priorities and business plans. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could impact our actual results include: developments relating to COVID-19; the Frontier restructuring and its proceedings under Chapter 11 of the United States Bankruptcy Code; our ability to attract new business and retain key clients; our ability to enter into multi-year contracts with our clients at appropriate rates; the potential for our clients or potential clients to consolidate; our clients deciding to enter into or further expand their insourcing activities; our ability to operate as an integrated company under the ibex brand; our ability to manage portions of our business that have long sales cycles and long implementation cycles that require significant resources and working capital; our ability to manage our international operations, particularly in Pakistan and the Philippines and increasingly in Jamaica and Nicaragua; our ability to comply with applicable laws and regulations, including those regarding privacy, data protection and information security; our ability to manage the inelasticity of our labor costs relative to short-term movements in client demand; our ability to realize the anticipated strategic and financial benefits of our relationship with Amazon; our ability to recruit, engage, motivate, manage and retain our global workforce; our ability to anticipate, develop and implement information technology solutions that keep pace with evolving industry standards and changing client demands; our ability to maintain and enhance our reputation and brand; and other factors discussed under the heading “Risk Factors” in our annual report on Form 20-F filed with the U.S. Securities and Exchange Commission on October 23, 2020 and any other risk factors we include in subsequent reports on Form 6-K. Because of these uncertainties, you should not make any investment decisions based on our estimates and forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements for any reason after the date of this press release whether as a result of new information, future events or otherwise.

Media Contact: Barry Canty, Senior Vice President of Marketing, ibex, (323) 217-5428,

IR Contact: Brinlea Johnson, The Blueshirt Group, 415.269.2645,



IBEX Limited
Unaudited Consolidated Statements of Financial Position
    
US$ in thousandsDecember 31, 2020 June 30, 2020
Assets   
Non-current assets   
Goodwill$11,832  $11,832 
Other intangible assets 3,174   2,781 
Property and equipment 103,397   84,588 
Investment in joint venture 330   331 
Deferred tax asset 2,400   2,223 
Warrant asset 2,161   2,611 
Other assets 5,532   4,834 
Total non-current assets$ 128,826  $ 109,200 
    
Current assets   
Trade and other receivables 74,056   62,579 
Due from related parties 1,922   1,587 
Cash and cash equivalents 74,615   21,870 
Total current assets$ 150,593  $ 86,036 
Total assets$ 279,419  $ 195,236 
    
Equity and liabilities   
Equity attributable to owners of the parent   
Share capital$2  $12 
Additional paid-in capital 158,008   96,207 
Other reserves 31,889   29,456 
Accumulated deficit (114,470)  (109,527)
Total equity$ 75,429  $ 16,148 
    
Non-current liabilities   
Deferred revenue$1,725  $434 
Lease liabilities 72,587   62,044 
Borrowings 4,217   3,782 
Deferred tax liability 87   117 
Other non-current liabilities 13,304   7,058 
Total non-current liabilities$ 91,920  $ 73,435 
    
Current liabilities   
Trade and other payables$51,158  $53,213 
Income tax payables 3,200   3,087 
Lease liabilities 10,858   12,668 
Borrowings 37,701   27,476 
Deferred revenue 4,825   3,470 
Due to related parties 4,328   5,739 
Total current liabilities$ 112,070  $ 105,653 
Total liabilities$ 203,990  $ 179,088 
Total equity and liabilities$ 279,419  $ 195,236 
    



IBEX Limited
Unaudited Consolidated Statements of Profit or Loss and Other Comprehensive Income / (Loss)
      
 Three months ended December 31, Six months ended December 31,
US$ in thousands, except share and per share amounts20202019 20202019
Revenue$117,181 $107,784  $225,952 $203,131 
      
Payroll and related costs 78,960  73,185   151,224  139,240 
Share-based payments 617  51   2,706  93 
Reseller commission and lead expenses 3,399  4,505   7,501  9,326 
Depreciation and amortization 6,983  6,413   13,422  12,113 
Other operating costs 20,888  16,017   45,678  30,153 
Income from operations$ 6,334 $ 7,613  $ 5,421 $ 12,206 
      
Finance expenses (2,374) (2,507)  (4,613) (4,814)
Income before taxation$ 3,960 $ 5,106  $ 808 $ 7,392 
      
Income tax expense (1,472) (349)  (1,743) (299)
Net income / (loss)$ 2,488 $ 4,757  $ (935)$ 7,093 
      
Other comprehensive income / (loss)     
      
Items that will be subsequently reclassified to profit or loss     
Foreign currency translation adjustment$(77)$(62) $(113)$(32)
Cash flow hedge - changes in fair value 52  -   85  - 
 $(25)$(62) $(28)$(32)
Total comprehensive income / (loss)$ 2,463 $ 4,695  $ (963)$ 7,061 
      
Earnings per share attributable to the ordinary equity holders of the parent     
Basic$0.14 $-  $(0.05)$- 
Diluted$0.13 $-  $(0.05)$- 
      
Weighted average shares outstanding     
Basic 17,988,508  12,556,972   17,183,501  12,556,972 
Diluted 18,719,169  12,755,131   17,931,867  12,755,131 
      
      



IBEX Limited 
Unaudited Consolidated Statements of Cash Flows 
         
 Three months ended December 31, Six months ended December 31, 
US$ in thousands2020 2019 2020 2019 
CASH FLOWS FROM OPERATING ACTIVITIES        
Income before taxation$3,960  $5,105  $808  $7,391  
Adjustments to reconcile income before taxation to net cash provided by operating activities:        
Depreciation and amortization 6,983   6,413   13,422   12,113  
Amortization of warrant asset 243   300   448   535  
(Gain) / loss on disposal of fixed assets -   16   (192)  16  
Foreign currency translation loss 55   206   203   359  
Fair value adjustment 2,159   133   5,745   882  
Phantom expense 129   15   254   28  
Share-based payments 488   36   2,452   65  
Provision for retirement benefit expense 66   108   144   134  
Allowance of expected credit losses 209   157   452   97  
Share of profit from investment in joint venture (103)  (175)  (226)  (339) 
Finance costs 2,374   2,507   4,613   4,814  
(Increase) / decrease in trade and other receivables (257)  7,860   (10,984)  3,197  
Increase in prepayments and other assets (381)  (63)  (697)  (536) 
(Decrease) / increase in trade and other payables and other liabilities (8,101)  (879)  1,052   (3,817) 
Cash generated from operations 7,824   21,739   17,494   24,939  
Interest paid (2,374)  (2,507)  (4,613)  (4,814) 
Income taxes paid (1,163)  (657)  (2,655)  (763) 
Net cash inflow from operating activities$ 4,287  $ 18,575  $ 10,226  $ 19,362  
         
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchase of property and equipment$(5,804) $(2,039) $(8,705) $(2,239) 
Purchase of other intangible assets (557)  (17)  (867)  (165) 
Capital repayment from joint venture 112   124   227   195  
Net cash outflow from investing activities$ (6,249) $ (1,932) $ (9,345) $ (2,209) 
         
CASH FLOWS FROM FINANCING ACTIVITIES        
Proceeds from line of credit$34,231  $43,419  $66,575  $78,211  
Repayments of line of credit (23,908)  (54,320)  (55,296)  (81,018) 
Proceeds from borrowings -   -   1,714   1,000  
Repayment of borrowings (3,031)  (1,690)  (5,827)  (3,389) 
Payment of related party loan (1,614)  -   (1,614)  -  
Net proceeds from initial public offering -   -   63,107   -  
Payment of listing related cost (227)  -   (1,052)  -  
Principal payments on lease obligations (8,575)  (3,145)  (11,630)  (6,145) 
Dividends paid -   (121)  (4,000)  (121) 
Net cash (outflow) / inflow from financing activities$ (3,124) $ (15,857) $ 51,977  $ (11,462) 
Effects of exchange rate difference on cash and cash equivalents (78)  (62)  (113)  (33) 
Net (decrease) / increase in cash and cash equivalents$(5,164) $724  $52,745  $5,658  
Cash and cash equivalents at beginning of the period$79,779  $13,807  $21,870  $8,873  
Cash and cash equivalents at end of the period$ 74,615  $ 14,531  $ 74,615  $ 14,531  
         
         



IBEX Limited


Reconciliation of IFRS Financial Measures to Non-GAAP Financial Measures

EXHIBIT 1: Adjusted net income and pro forma fully diluted adjusted earnings per share

We define “Adjusted net income” as net income / (loss) before the effect of the following items: non-recurring expenses (including litigation and settlement expenses, costs related to COVID-19, and expenses related to our initial public offering), other income, fair value adjustment related to the Amazon warrant, share-based payments, foreign exchange gains or losses, and impairment losses, as applicable, net of the tax effect of such adjustments. We define “pro forma fully diluted adjusted earnings per share” as Adjusted net income for the period divided by the weighted average fully diluted shares outstanding for the current periods.

            
 Three months ended December 31, Six months ended December 31, 
 20202019 2020 2019 
US$ in thousands, except share and per share amountsAmountPer ShareAmountPer Share AmountPer Share AmountPer Share 
Net income / (loss)$ 2,488 $ 0.13 $ 4,757 $ 0.25 (3)$ (935)$ (0.05) $ 7,093 $ 0.40 (3)
Non-recurring expenses 1,593 $0.09  596 $0.03   5,991 $0.33   596 $0.03  
Other income (140)$(0.01) (188)$(0.01)  (291)$(0.02)  (387)$(0.02) 
Fair value adjustment 2,159 $0.12  133 $0.01   5,745 $0.32   882 $0.05  
Share-based payments 617 $0.03  51 $0.00   2,706 $0.15   93 $0.01  
Foreign exchange losses 55 $0.00  206 $0.01   203 $0.01   359 $0.02  
Total adjustments$ 4,284 $ 0.23 $ 798 $ 0.04  $ 14,354 $ 0.80  $ 1,543 $ 0.09  
Tax impact of adjustments(1) (611)$(0.03) 38 $0.00   (2,057)$(0.11)  101 $0.01  
Adjusted net income$ 6,161 $ 0.33 $ 5,593 $ 0.30  $ 11,363 $ 0.63  $ 8,737 $ 0.49  
Adjusted net income margin 5.3%  5.2%   5.0%   4.3%  
            
IFRS Weighted average fully diluted shares outstanding 18,719,169   12,755,131    17,931,867    12,755,131   
Adjustment for share re-capitalization on August 7, 2020 -   5,964,039    -    5,176,736   
Pro forma fully diluted shares outstanding and pro forma adjusted earnings per share(2) 18,719,169 $ 0.33  18,719,169 $ 0.30   17,931,867 $ 0.63   17,931,867 $ 0.49  

(1) The tax impact of each adjustment is calculated using the effective tax rate in the relevant jurisdiction.

(2) We provide “pro forma fully diluted adjusted earnings per share” because the share structure for the prior year does not reflect the re-capitalization that occurred in connection with ibex’s initial public offering on August 7, 2020. For purposes of this calculation, we have included 18,719,169 shares for the three months ended December 31, 2019, and 17,931,867 shares for the six months ended December 31, 2019, the weighted average fully diluted shares outstanding for the three and six months ended December 31, 2020, respectively, in order to enhance comparability between the current and prior year periods. Beginning with the first quarter of fiscal year 2022, our share structure will be comparable year over year, and this measure will reflect the respective periods’ weighted average fully diluted shares outstanding.

(3) On an IFRS basis, this amount is $0.00. For purposes of this reconciliation, it represents the proforma impact of the share re-capitalization on August 7, 2020.

EXHIBIT 2: EBITDA and Adjusted EBITDA

We define “EBITDA” as net (loss) / income before the effect of the following items: finance expenses (including finance costs related to lease liabilities), income tax expense / (benefit), and depreciation and amortization (including depreciation of right-of-use assets). We define “Adjusted EBITDA” as EBITDA before the effect of the following items: non-recurring expenses (including litigation and settlement expenses, costs related to COVID-19, and expenses related to our initial public offering), other income, fair value adjustment related to the Amazon warrant, share-based payments, foreign exchange gains or losses, and impairment losses, as applicable.

 Three months ended December 31,Six months ended December 31,
US$ in thousands2020201920202019
Net income / (loss)$ 2,488 $ 4,757  $ (935)$ 7,093 
Finance expense 2,374  2,507   4,613  4,814 
Income tax expense 1,472  349   1,743  299 
Depreciation and amortization 6,983  6,413   13,422  12,113 
EBITDA $ 13,317 $ 14,026  $ 18,843 $ 24,319 
Non-recurring expenses 1,593  596   5,991  596 
Other income (140) (188)  (291) (387)
Fair value adjustment 2,159  133   5,745  882 
Share-based payments 617  51   2,706  93 
Foreign exchange losses 55  206   203  359 
Adjusted EBITDA$ 17,601 $ 14,824  $ 33,197 $ 25,862 
Adjusted EBITDA margin 15.0% 13.8%  14.7% 12.7%
      

EXHIBIT 3: Free cash flow

We define “free cash flow” as net cash provided by operating activities less capital expenditures and lease payments on right-of-use assets.

      
 Three months ended December 31, Six months ended December 31,
US$ in thousands20202019 20202019
      
Net cash provided by operating activities$ 4,287 $ 18,575 $ 10,226 $ 19,362
      
Less:     
Capital expenditures 7,165  4,094  11,690  13,432
Lease payments on right-of-use assets 2,843  2,338  5,171  4,727
Free cash flow$ (5,721)$ 12,143 $ (6,635)$ 1,203
      

EXHIBIT 4: Net debt

We define “net debt” as total borrowings less cash and cash equivalents.

   
US$ in thousandsDecember 31, 2020June 30, 2020
Borrowings  
Non-current$4,217$3,782
Current 37,701 27,476
 $41,918$31,258
Leases  
Non-current 72,587 62,044
Current 10,858 12,668
 $83,445$74,712
Total Debt$125,363$105,970
Cash 74,615 21,870
Net debt$ 50,748$ 84,100



EN
18/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IBEX

 PRESS RELEASE

ibex Appoints Amanda Gunter Vice President of Business Development

ibex Appoints Amanda Gunter Vice President of Business Development WASHINGTON, March 26, 2024 (GLOBE NEWSWIRE) -- ibex, a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced that Amanda Gunter has been named Vice President of Business Development. Gunter brings more than a decade of experience as a sales leader in the contact center industry. In her role, Gunter will be responsible for growing new business for ibex and report to John Thompson, Head of Sales at ibex. “We are excited to welcome Amanda to the ibex ...

 PRESS RELEASE

ibex Wins 2024 Artificial Intelligence Excellence Award

ibex Wins 2024 Artificial Intelligence Excellence Award Wave iX Recognized for Exceptional Innovation in Empowering Agents to Deliver Greater Customer Experience WASHINGTON, March 20, 2024 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced that it was named a winner of the by the Business Intelligence Group. The Artificial Intelligence Excellence Awards recognize those organizations, products and people who bring Artificial Intelligence (AI) to life and apply it to solve ...

 PRESS RELEASE

ibex Wave iX Wins 2024 CUSTOMER Product of the Year Award

ibex Wave iX Wins 2024 CUSTOMER Product of the Year Award Wave iX Honored for Exceptional Innovation in Redefining Customer Experience WASHINGTON, March 14, 2024 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, announced today that , a global, integrated media company, has named ibex’s AI-powered Wave iX solution suite a winner of the 2024 . The 2024 CUSTOMER Product of the Year Award recognizes vendors that are advancing the call center, CRM and teleservices industries one solut...

 PRESS RELEASE

ibex Wins Gold Award As Top BPO Services Exporter in Pakistan

ibex Wins Gold Award As Top BPO Services Exporter in Pakistan Recognized by the Pakistan Software Export Board as a Top BPO Services Exporter and One of the Largest IT/IT-enabled Services Exporters in Pakistan WASHINGTON, Feb. 21, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced that it has received a Gold award in the category of Top Exporter in the BPO services sector by the . ibex was also recognized for being one of the Largest Exporters for IT/IT-enabled services i...

 PRESS RELEASE

IBEX Announces Second Quarter of Fiscal Year 2024 Financial Results

IBEX Announces Second Quarter of Fiscal Year 2024 Financial Results WASHINGTON, Feb. 08, 2024 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its second fiscal quarter ended December 31, 2023. “We delivered against a number of our key objectives in the second quarter, highlighted by the eight new client wins in the quarter, totaling twelve in the first half of the fiscal year versus seven in the prior year period,” commented Bob Dechant, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch